Axsome Therapeutics Stock Return On Equity

AXSM Stock  USD 79.17  2.45  3.19%   
Axsome Therapeutics fundamentals help investors to digest information that contributes to Axsome Therapeutics' financial success or failures. It also enables traders to predict the movement of Axsome Stock. The fundamental analysis module provides a way to measure Axsome Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axsome Therapeutics stock.
As of the 28th of March 2024, Return On Equity is likely to grow to -1.19.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Axsome Return On Equity Analysis

Axsome Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Axsome Therapeutics Return On Equity

(1.19)

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Axsome Therapeutics Return On Equity

    
  -1.59  
Most of Axsome Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axsome Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Axsome Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Axsome Therapeutics is extremely important. It helps to project a fair market value of Axsome Stock properly, considering its historical fundamentals such as Return On Equity. Since Axsome Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Axsome Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Axsome Therapeutics' interrelated accounts and indicators.
0.860.71-0.8-0.740.810.860.870.850.89-0.190.510.430.410.590.550.82-0.240.80.570.450.890.880.74
0.860.63-0.72-0.940.950.960.991.00.94-0.320.610.480.150.70.120.98-0.230.980.80.60.920.90.88
0.710.63-0.2-0.340.450.660.690.560.440.03-0.08-0.1-0.24-0.050.660.50.040.60.1-0.140.440.410.3
-0.8-0.72-0.20.78-0.8-0.69-0.69-0.76-0.910.33-0.78-0.67-0.79-0.89-0.13-0.770.41-0.67-0.73-0.78-0.92-0.92-0.84
-0.74-0.94-0.340.78-0.98-0.86-0.92-0.96-0.940.41-0.8-0.62-0.29-0.880.12-0.970.3-0.95-0.93-0.81-0.92-0.9-0.97
0.810.950.45-0.8-0.980.860.950.960.94-0.420.770.60.320.850.020.96-0.310.970.890.770.930.890.95
0.860.960.66-0.69-0.860.860.950.950.91-0.280.550.530.130.610.20.94-0.330.910.660.450.870.870.78
0.870.990.69-0.69-0.920.950.950.980.91-0.30.580.440.120.660.180.96-0.220.990.760.560.90.870.86
0.851.00.56-0.76-0.960.960.950.980.96-0.330.660.520.210.760.081.0-0.250.970.840.650.940.930.91
0.890.940.44-0.91-0.940.940.910.910.96-0.340.730.610.470.850.110.96-0.340.890.840.720.990.990.92
-0.19-0.320.030.330.41-0.42-0.28-0.3-0.33-0.34-0.46-0.51-0.22-0.450.23-0.360.67-0.37-0.48-0.41-0.3-0.28-0.4
0.510.61-0.08-0.78-0.80.770.550.580.660.73-0.460.850.570.92-0.210.67-0.470.640.760.910.710.690.84
0.430.48-0.1-0.67-0.620.60.530.440.520.61-0.510.850.530.76-0.140.53-0.780.490.550.610.550.540.58
0.410.15-0.24-0.79-0.290.320.130.120.210.47-0.220.570.530.650.110.23-0.390.110.350.570.510.520.42
0.590.7-0.05-0.89-0.880.850.610.660.760.85-0.450.920.760.65-0.250.78-0.410.710.90.930.850.830.9
0.550.120.66-0.130.120.020.20.180.080.110.23-0.21-0.140.11-0.250.010.060.06-0.29-0.330.130.12-0.09
0.820.980.5-0.77-0.970.960.940.961.00.96-0.360.670.530.230.780.01-0.280.960.880.680.940.930.92
-0.24-0.230.040.410.3-0.31-0.33-0.22-0.25-0.340.67-0.47-0.78-0.39-0.410.06-0.28-0.25-0.27-0.26-0.27-0.26-0.27
0.80.980.6-0.67-0.950.970.910.990.970.89-0.370.640.490.110.710.060.96-0.250.810.630.880.840.89
0.570.80.1-0.73-0.930.890.660.760.840.84-0.480.760.550.350.9-0.290.88-0.270.810.870.830.820.92
0.450.6-0.14-0.78-0.810.770.450.560.650.72-0.410.910.610.570.93-0.330.68-0.260.630.870.740.720.9
0.890.920.44-0.92-0.920.930.870.90.940.99-0.30.710.550.510.850.130.94-0.270.880.830.740.990.93
0.880.90.41-0.92-0.90.890.870.870.930.99-0.280.690.540.520.830.120.93-0.260.840.820.720.990.9
0.740.880.3-0.84-0.970.950.780.860.910.92-0.40.840.580.420.9-0.090.92-0.270.890.920.90.930.9
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Axsome Total Stockholder Equity

Total Stockholder Equity

200.53 Million

At this time, Axsome Therapeutics' Total Stockholder Equity is very stable compared to the past year.
Based on the latest financial disclosure, Axsome Therapeutics has a Return On Equity of -1.5921. This is 93.36% lower than that of the Pharmaceuticals sector and 95.63% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

Axsome Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axsome Therapeutics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axsome Therapeutics could also be used in its relative valuation, which is a method of valuing Axsome Therapeutics by comparing valuation metrics of similar companies.
Axsome Therapeutics is currently under evaluation in return on equity category among related companies.

Axsome Fundamentals

About Axsome Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Axsome Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axsome Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axsome Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Return On Equity(1.25)(1.19)

Pair Trading with Axsome Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axsome Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Axsome Stock

  0.72MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.66YS YS Biopharma Report 22nd of April 2024 PairCorr
  0.66DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.59MESO Mesoblast TrendingPairCorr
  0.56TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
The ability to find closely correlated positions to Axsome Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axsome Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axsome Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axsome Therapeutics to buy it.
The correlation of Axsome Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axsome Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axsome Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axsome Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Axsome Therapeutics is a strong investment it is important to analyze Axsome Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Axsome Therapeutics' future performance. For an informed investment choice regarding Axsome Stock, refer to the following important reports:
Check out Axsome Therapeutics Piotroski F Score and Axsome Therapeutics Altman Z Score analysis.
To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Axsome Stock analysis

When running Axsome Therapeutics' price analysis, check to measure Axsome Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axsome Therapeutics is operating at the current time. Most of Axsome Therapeutics' value examination focuses on studying past and present price action to predict the probability of Axsome Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axsome Therapeutics' price. Additionally, you may evaluate how the addition of Axsome Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is Axsome Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axsome Therapeutics. If investors know Axsome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axsome Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.27)
Revenue Per Share
5.957
Quarterly Revenue Growth
1.935
Return On Assets
(0.25)
Return On Equity
(1.59)
The market value of Axsome Therapeutics is measured differently than its book value, which is the value of Axsome that is recorded on the company's balance sheet. Investors also form their own opinion of Axsome Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Axsome Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axsome Therapeutics' market value can be influenced by many factors that don't directly affect Axsome Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axsome Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Axsome Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axsome Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.